InMode to Participate in Upcoming Investor Conferences

Rhea-AI Summary

InMode (Nasdaq: INMD) will participate in three investor conferences in November 2025: the UBS Global Healthcare Conference (in-person one-on-ones, Palm Beach Gardens, FL) on Monday, November 10; the Jefferies Global Healthcare Conference (in-person fireside chat and one-on-ones, London, U.K.) with a fireside chat at 4:00 pm GMT on Tuesday, November 18 and a live webcast available; and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (in-person one-on-ones, New York, NY) on Thursday, November 20. Presenters include CEO Moshe Mizrahy and CFO Yair Malca.

News Market Reaction – INMD

-1.41%

1 alert

-1.41% News Effect

On the day this news was published, INMD declined 1.41%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

YOKNEAM, Israel, Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in November:

UBS Global Healthcare Conference

Presenter: Yair Malca, Chief Financial Officer

Format: In-person one-on-one meetings

Location: Palm Beach Gardens, FL

When: Monday, November 10

Jefferies Global Healthcare Conference

Presenter: Moshe Mizrahy, Chief Executive Officer

Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst, and one-on-one meetings

Location: London, U.K.

When: Tuesday, November 18, Fireside Chat at 4:00 pm GMT

A live webcast of the presentation can be accessed here.

Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Presenter: Yair Malca, Chief Financial Officer

Format: In-person one-on-one meetings

Location: New York, NY

When: Thursday, November 20

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com 

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-in-upcoming-investor-conferences-302598806.html

SOURCE InMode Ltd.

FAQ

When will InMode (INMD) present at the Jefferies Global Healthcare Conference in 2025?

InMode CEO Moshe Mizrahy will present on Tuesday, November 18, 2025 with a fireside chat at 4:00 pm GMT and a live webcast.

How can investors watch InMode (INMD) at the Jefferies fireside chat on November 18, 2025?

A live webcast of the presentation will be available; investors should access it via the company's investor relations webcast link.

Who from InMode (INMD) will attend the UBS Global Healthcare Conference on November 10, 2025?

CFO Yair Malca will attend UBS Global Healthcare Conference for in-person one-on-one meetings on Monday, November 10, 2025 in Palm Beach Gardens, FL.

What is InMode's (INMD) schedule at the Canaccord Genuity MedTech forum in November 2025?

CFO Yair Malca will conduct in-person one-on-one meetings at the Canaccord Genuity MedTech forum on Thursday, November 20, 2025 in New York, NY.

Will investors be able to meet InMode (INMD) management in person during November 2025 conferences?

Yes. InMode management will hold in-person one-on-one meetings at UBS (Nov 10) and Canaccord Genuity (Nov 20), plus in-person sessions at Jefferies (Nov 18).

Which InMode (INMD) executives are presenting at the November 2025 investor conferences?

Presenters include Moshe Mizrahy, chief executive officer, and Yair Malca, chief financial officer.